Dow Jones 30 Stocks SEC Filings — March 19, 2026

19-03-2026

The Gabelli Global Utility & Income Trust has filed a definitive proxy statement for its Annual Meeting of Shareholders on May 11, 2026, at 10:00 a.m. ET, to elect two Trustees: Salvatore J. Zizza by common and preferred shareholders voting together as a single class, and Leslie F. Foley by preferred shareholders as a separate class. The record date is March 12, 2026, with 5,990,356 Common Shares, 10,977 Series A Preferred Shares, and 484,590 Series B Preferred Shares outstanding; no dividend arrearages exist on Preferred Shares. GAMCO Investors, Inc. and affiliates beneficially own 9.5% of Common Shares.

• ·Quorum requires holders of one-third of outstanding shares entitled to vote; separate one-third quorum for Preferred Shares Trustee election.
• ·Board divided into three classes with staggered three-year terms; all nine Trustees are independent (non-interested persons).
• ·No dividend arrearages on Preferred Shares; Preferred holders entitled to elect majority of Trustees if arrears persist for two years.
• ·Proxy materials mailing begins on or about April 1, 2026; fiscal year ended December 31, 2025.

19-03-2026

The Gabelli Convertible and Income Securities Fund Inc. (GCV) has filed a definitive proxy statement for its Annual Meeting of Stockholders on May 11, 2026, primarily to elect four directors: three (Vincent D. Enright, Anthonie C. van Ekris, Salvatore J. Zizza) by holders of common and 5.20% Series H Preferred Stock voting together, and one (Anthony S. Colavita) by Preferred Stock holders separately. As of the March 12, 2026 record date, 20,050,323 common shares and 607,500 Preferred shares were outstanding, with no dividend arrearages reported. Major holders include GAMCO Investors, Inc. affiliates (9.6% of common) and Regina Pitaro (46.9% of Preferred).

• ·Board consists of 13 directors, 10 of whom are independent (non-interested persons under 1940 Act).
• ·Preferred stockholders elect two directors separately; currently Anthony S. Colavita and Werner J. Roeder.
• ·No dividend arrearages on Preferred Stock.
• ·Fiscal year ended September 30, 2025; annual report available upon request.
• ·Quorum requires majority of votes entitled to be cast; Preferred election requires majority of outstanding Preferred shares.

19-03-2026

UPS filed its DEF 14A Proxy Statement on March 19, 2026, for the 2026 Annual Meeting of Shareowners, proposing the election of directors including Carol Tome, Brian Dykes, Nando Cesarone, Kate Gutmann, and Bala Subramanian (terms expiring May 9, 2025), an advisory vote on 2025 Named Executive Officer compensation, approval of the 2026 Omnibus Incentive Compensation Plan, ratification of auditors, and responses to shareowner proposals on Class A voting power reduction and community impact reporting. The Board Chair letter notes 2025 as a pivotal year marked by a strategic shift to reduce non-value volume from the largest customer to prioritize high-value growth capacity. No specific compensation amounts or period-over-period changes are detailed in the provided filing excerpt.

• ·Proxy items include Proposal 5: Shareowner proposal to reduce Class A stock voting power from 10 to 1 vote per share.
• ·Proposal 6: Shareowner proposal for independent evaluation of UPS operations' impacts on BIPOC and low-income communities.
• ·Proposal 7: Shareowner proposal for report on aligning operations with carbon neutrality goal.
• ·Compensation disclosures cover 2021-2025 periods for PEO and Non-PEO NEOs, including equity awards, pension changes, and pay versus performance.

19-03-2026

Bancroft Fund Ltd. has issued a proxy statement for its Annual Meeting of Shareholders on May 11, 2026, at 8:00 a.m. ET, to elect four Trustees: three (Kinchen C. Bizzell, James P. Conn, Frank J. Fahrenkopf, Jr.) by common and preferred shareholders voting together as a single class, and one (Michael J. Melarkey) by preferred shareholders as a separate class. The record date is March 12, 2026, with 5,822,431 common shares and 1,098,623 preferred shares outstanding. Major shareholders owning 5% or more include Saba Capital Management, L.P. (6.2% of common shares), Ameriprise Financial Inc. (5.2% of common shares), and Americo Investment Advisors Inc. (5.5% of preferred shares).

• ·Quorum requires holders of one-third of outstanding shares entitled to vote
• ·Preferred shareholders elect one Trustee (Michael J. Melarkey) as a separate class; three others jointly with common shareholders
• ·No dividend arrearages on Preferred Shares as of proxy date
• ·Fiscal year ended September 30, 2025
• ·Meeting location: Indian Harbor Yacht Club, 710 Steamboat Road, Greenwich, Connecticut, 06830
• ·Proxy materials mailed on or about April 1, 2026

19-03-2026

RYVYL Inc. adjourned its Special Meeting of Shareholders on March 18, 2026, to vote on the planned merger with RTB Digital, Inc. (Roundtable), reconvening virtually on March 25, 2026, at 4pm EST. Approximately 99% of votes cast supported the merger, with 43% of entitled shares voted, requiring only an additional 7% in favor to approve; however, the adjournment highlights that quorum or majority threshold has not yet been met. The company urges unvoted shareholders to participate promptly via Kingsdale Advisors.

• ·Record date for Special Meeting: February 6, 2026 (unchanged)
• ·Virtual meeting link: http://www.virtualshareholdermeeting.com/RVYL2026SM
• ·Voting assistance contact: Kingsdale Advisors at 888-518-6812 or contactus@kingsdaleadvisors.com

19-03-2026

Artificial Intelligence Technology Solutions, Inc. (AITX) filed an 8-K on March 19, 2026, under Items 8.01 and 9.01, announcing the issuance of a press release titled 'AITX's RAD Books Hundreds of SARA Licenses as Customers Expand After Initial Deployment.' The press release is furnished as Exhibit 99.1 and is not deemed filed or material.

• ·Filed by newsfilecorp.com
• ·Registrant details: Nevada incorporation, Commission File Number 000-55079, IRS Employer Identification No. 27-2343603, principal offices at 10800 Galaxie Avenue, Ferndale, Michigan 48220

19-03-2026

AMERICAN VANGUARD CORPORATION (as Holdings) and AMVAC CHEMICAL CORPORATION (as Borrower) entered into a Credit and Guaranty Agreement dated March 13, 2026, with Wilmington Trust, National Association as Administrative Agent and certain lenders, establishing a senior secured term loan facility with an aggregate principal amount of $225 million. The facility provides financing subject to covenants, representations, and events of default, with interest rates starting at Term SOFR plus 8.25% or Base Rate plus 7.25%, eligible to step down based on improvements in the Consolidated Total Leverage Ratio below thresholds like 4.00:1.00. No prior period financial performance data or comparisons are disclosed in the filing.

• ·Compliance Certificate due two business days after quarterly financials for fiscal quarter ending June 30, 2026, to potentially adjust Applicable Margin.
• ·ABL Facility permitted if approved by Required Lenders, secured junior to term loan on non-ABL Priority Collateral.

19-03-2026

Catalyst Pharmaceuticals, Inc. (CPRX) filed an 8-K/A on March 19, 2026, to correct a scrivener’s error in the signature date of its prior 8-K filed on March 18, 2026. The underlying event discloses a District Court for the District of New Jersey order delaying the bench trial against Hetero USA, Inc. from March 23, 2026, to May 18, 2026, concerning the validity of the company's Orange Book-listed patents for FIRDAPSE® that expire in 2032, 2034, and 2037. No other changes were made to the original filing.

• ·District Court for the District of New Jersey issued the trial delay order.
• ·Patents are Orange Book-listed.

19-03-2026

Modiv Industrial, Inc. announced it will report financial results for the quarter and full year ended December 31, 2025, after market close on March 25, 2026. The company declared a quarterly dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock, payable April 15, 2026, and monthly distributions of $0.10 per share on Class C Common Stock for April, May, and June 2026, equivalent to an annualized $1.20 per share. No comparative financial metrics were provided in the filing.

• ·Board authorized dividends and distributions on March 17, 2026.
• ·Series A Preferred record date: March 31, 2026.
• ·Common Stock record dates: April 30, May 29, June 30, 2026.
• ·Common Stock payment dates: May 15, June 15, July 15, 2026.

19-03-2026

Innventure, Inc. filed a Form S-3 registration statement on March 18, 2026, to register the resale of common stock by certain selling stockholders, consolidating three prior Form S-1 registrations (File Nos. 333-282971, 333-286558, and 333-291034). The filing covers already issued outstanding shares or those issuable upon conversion or exercise of previously disclosed securities, with no new equity issuances or stockholder dilution. The company will not receive proceeds from these resales, except potentially from its Standby Equity Purchase Agreement with YA II PN, Ltd., dated October 24, 2023, or cash exercises of certain warrants.

• ·Commission File Number: 001-42303
• ·I.R.S. Employer Identification Number: 93-4440048
• ·Prior Form S-1 File Nos.: 333-282971, 333-286558, 333-291034

19-03-2026

On March 17, 2026, The Cannabist Company Holdings Inc. secured a further extension of a forbearance agreement from an ad hoc group of noteholders for its 9.25% Senior Secured Notes due December 31, 2028, and 9.00% Senior Secured Convertible Notes due December 31, 2028, postponing any exercise of remedies until March 25, 2026. This development signals ongoing financial stress and potential covenant issues under the amended indenture. No financial metrics or performance data were disclosed.

• ·Registrant is an emerging growth company.
• ·Principal executive offices: 321 Billerica Road, Chelmsford, Massachusetts 01824.
• ·Telephone: (978) 910-1486.
• ·No securities registered pursuant to Section 12(b) of the Act.

19-03-2026

Global Net Lease, Inc. announced the declaration of quarterly dividends on its preferred stocks on March 19, 2026: $0.453125 per share for 7.25% Series A, $0.4296875 per share for 6.875% Series B, $0.46875 per share for 7.50% Series D, and $0.4609375 per share for 7.375% Series E, all payable on April 15, 2026 to holders of record on April 3, 2026. These dividends align with the stated coupon rates, providing expected returns to preferred shareholders.

• ·All preferred stocks listed on New York Stock Exchange
• ·Company address: 650 Fifth Avenue, 30th Floor, New York, New York 10019
• ·Telephone: (332) 265-2020

19-03-2026

Republic Airways Holdings Inc. reported FY2025 revenues of $1,676.5M, up 13.7% YoY from $1,474.0M, with operating income rising 22.8% to $168.3M and Adjusted EBITDA surging 32.9% to $341.7M, driving net income to $76.2M (+18.0%). However, executive separation and merger-related costs jumped to $47.1M from $3.2M, total liquidity declined 1.1% to $319.9M, and net cash used in investing activities ballooned to $350.9M. In FY2024 vs FY2023, revenues grew modestly 3.1% but Adjusted EBITDA fell 12.8% to $257.2M.

• ·Net cash provided by operating activities increased 42.4% to $322.0M in FY2025 from $226.1M.
• ·Net cash used in investing activities worsened to $350.9M in FY2025 from $105.5M.
• ·Income tax expense rose 66.8% to $37.2M in FY2025.
• ·Depreciation and amortization increased 7.9% to $126.3M in FY2025.
• ·Marketable securities declined 15.3% to $162.2M in FY2025.

19-03-2026

United Bancorp, Inc. filed an amended Form 10-K/A for the fiscal year ended December 31, 2025, on March 19, 2026, primarily incorporating exhibits by reference including governance documents, executive change-in-control agreements, supplemental life insurance and deferred compensation plans, stock incentive plans, subordinated debt agreements, the 2025 Annual Report, insider trading policies, subsidiaries list, audit consents, and Sarbanes-Oxley certifications. Signatures were provided by CEO Scott A. Everson, CFO Randall M. Greenwood, and directors on March 18, 2026. No financial performance metrics, period-over-period comparisons, or material updates to results are detailed in the filing content.

• ·Filing covers FY 2025 (January 1, 2025 to December 31, 2025).
• ·Key exhibits include Clawback Policy (Exhibit 97) and Insider Trading Policies and Procedures (Exhibit 19).

19-03-2026

Vine Hill Capital Investment Corp. announced via press release that the physical location for its Extraordinary General Meeting on March 27, 2026, at 10:00 a.m. ET—to approve the proposed business combination with CoinShares International Limited and Odysseus Holdings Limited—has changed to the offices of Paul Hastings LLP in Los Angeles, CA. The virtual meeting link remains unchanged at https://www.cstproxy.com/vinehillcapital/2026, with no alterations to the date, time, or agenda. This update is part of ongoing M&A communications ahead of the shareholder vote.

• ·Definitive proxy statement filed with SEC on March 16, 2026.
• ·Shareholder record date for voting: March 2, 2026.
• ·New physical venue: 515 South Flower Street, 25th Floor, Los Angeles, California 90071.
• ·Registrant is an emerging growth company.

19-03-2026

Kolibri Global Energy Inc. (KGEI), a foreign private issuer and emerging growth company, filed its Form 40-F Annual Report for the fiscal year ended December 31, 2025, incorporating by reference its Annual Information Form (AIF), Management’s Discussion and Analysis (MD&A), and audited consolidated financial statements for 2025 and 2024 prepared under IFRS. The company reported 35,471,833 common shares outstanding as of December 31, 2025, with shares listed on Nasdaq Capital Market (KGEI) and Toronto Stock Exchange. Management certified effective disclosure controls and internal controls over financial reporting, with no material changes or errors noted.

• ·Audit committee financial expert: Doug Urch (independent).
• ·Principal executive offices: 925 Broadbeck Drive, Suite 220, Thousand Oaks, CA 91320.
• ·Shareholder special meeting on November 25, 2025, limited authorized common shares to 37,367,894 without approval.
• ·No off-balance sheet arrangements material to investors.
• ·No waivers to Code of Business Conduct and Ethics in 2025.

19-03-2026

DevvStream Corp. reduced outstanding debt by approximately $5.9 million net of a new $700,000 0% interest loan from Helena Partners, through Focus Impact Partners converting $5.5 million of 5.3% notes and fees into equity at a 12.9% premium, and prepaying $1.1 million to Helena from released $1.2 million collateral. These moves strengthen the balance sheet and signal partner confidence. However, forward-looking risks highlight potential insufficient liquidity from the new loan, Nasdaq delisting threats, and operational constraints from existing debt.

• ·FIP 5.3% convertible notes due November 2026
• ·Helena convertible note dated July 17, 2025
• ·Helena interest waiver through May 2026
• ·New Helena loan due March 2027
• ·Announcement date: March 13, 2026
• ·Filing date: March 19, 2026

19-03-2026

Aveanna Healthcare Holdings reported robust Q4 2025 revenue growth of 27.4% to $662.5M and Adjusted EBITDA increase of 54.0% to $85.0M, with full-year 2025 revenue up 20.2% to $2.43B and Adjusted EBITDA surging 74.8% to $320.9M, driven by gains across PDS, HHH, and MS segments. However, Q4 gross margin declined slightly to 32.2% from 33.0% YoY. The company announced a definitive agreement to acquire Family First Homecare for $175.5M, expected to close in Q2 2026, and maintained FY2026 guidance of $2.54-2.56B revenue and $318-322M Adjusted EBITDA.

• ·PDS segment drove bulk of Q4 revenue growth with +$118.5M YoY; HHH +$14.9M; MS +$9.2M.
• ·FY2025 gross margin improved to 33.3% from 31.4% YoY.
• ·As of Jan 3, 2026: $193.3M cash, $110M incremental securitization capacity, $225.5M revolver capacity (undrawn), $24.5M letters of credit.
• ·Interest rate hedges: $520M swaps, $880M caps at SOFR 2.96%.
• ·Family First Homecare operates 27 locations in 7 states (FL, IL, IA, PA, SD, TX, NC).

19-03-2026

SOLV Energy reported record Q4 and FY 2025 results, with Q4 revenue surging 80% YoY to $794M and FY revenue increasing 35% to $2.49B, while Adjusted EBITDA rose 89% to $100M in Q4 and 107% to $342M for the year. Gross margins improved significantly FY to 18.6% from 14.0%, but dipped slightly in Q4 to 18.1% from 18.5%. Backlog grew 87% to $8B year-end, supported by $552.5M net IPO proceeds used to repay debt and upsize revolver to $200M, with 2026 guidance of $3.72B-$3.82B revenue and $400M-$420M Adjusted EBITDA.

• ·Raised $552.5M net proceeds from IPO in February 2026
• ·Repaid outstanding term loan
• ·Over 20 GW under contract for O&M services
• ·2026 Gross Profit guidance: $580M to $620M (15.6%-16.2% margin)

19-03-2026

Acrivon Therapeutics reported a narrower net loss of $77.9M for the year ended December 31, 2025, compared to $80.6M in 2024, primarily due to reduced operating expenses including R&D down 6% to $60.0M and G&A down 4% to $24.1M. However, total assets declined 34% to $129.7M from $196.6M, driven by a 45% drop in short-term investments to $77.1M and ongoing cash usage, while stockholders' equity fell 36% to $112.5M with no significant financing inflows. Liquidity remained strained as net cash used in operating activities was $63.7M, slightly improved from $65.7M.

• ·Net loss per share improved to $(2.02) from $(2.38).
• ·Accumulated deficit increased to $(274.9M) from $(197.0M).
• ·No new equity financing in 2025 after $123.8M raised via private placement and pre-funded warrants in 2024.
• ·Investing activities provided $66.1M cash in 2025 (from investment maturities) vs used $51.8M in 2024.

19-03-2026

Intuitive Machines reported Q4 2025 revenue of $44.8 million driven by CLPS, OMES III, and NSNS, achieving 19% positive gross margin amid year-long improvements, while full-year free cash flow use totaled $56 million, an $11.7 million YoY improvement reflecting disciplined capital management. The company completed the $800 million acquisition of Lanteris Space Systems and KinetX Aerospace, secured a $175 million strategic investment and $151 billion ceiling MDA SHIELD IDIQ contract, with February backlog at $943 million. For 2026, it guides $900 million to $1 billion revenue with positive Adjusted EBITDA.

• ·Awarded to support SDA Proliferated Warfighter Space Architecture tranche 3 tracking layer, started production on tranche 2, finishing tranche 1 delivery
• ·Launched EchoStar XXV in Q1 2026, joining fleet of over 100 spacecraft

19-03-2026

Datavault AI Inc. (DVLT) reported its first-ever profitable quarter in Q4 FY25 with revenue of $33.8M (up 3,650% YoY from <$1M), GAAP operating profit of $4.2M (vs. $6.3M loss), and net profit of $0.661M. FY25 revenue surged 1,362% YoY to $39.1M with gross margins expanding to 78% from 14%, supported by a strong balance sheet showing $116M working capital, $142.9M current assets, and no long-term debt; however, accumulated deficit widened to $377.4M from $298.5M. The company reiterates its FY26 revenue target of $200M, implying ~400% YoY growth.

• ·Acquired CompuSystems, Inc. in May 2025 and API Media Innovations Inc. recently.
• ·Investor webcast scheduled for March 19, 2026 at 8:30 a.m. ET.
• ·10-K filed with SEC on March 18, 2026.
• ·Crypto assets: $92.2M as of Dec 31, 2025.
• ·Intangible assets: $94.8M as of Dec 31, 2025 (up from $92.6M).

19-03-2026

Vericel Corporation filed definitive additional proxy soliciting materials for its 2026 Annual Meeting of Shareholders, to be held virtually on April 29, 2026 at 9:00 a.m. ET. Shareholders are asked to vote on the election of seven director nominees, an advisory approval of named executive officer compensation, and ratification of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026, with the Board recommending 'For' all proposals. Voting must be completed by April 28, 2026, and proxy materials including the Notice, Proxy Statement, and Form 10-K are available online at www.ProxyVote.com.

• ·Annual Meeting is virtual only at www.virtualshareholdermeeting.com/VCEL2026; no in-person attendance.
• ·Request paper/email copies of materials by April 15, 2026 via www.ProxyVote.com, 1-800-579-1639, or sendmaterial@proxyvote.com.
• ·Company address: 64 Sidney Street, Cambridge, MA 02139.

19-03-2026

Lincoln Electric Holdings Inc's 2026 Proxy Statement details the virtual annual meeting on April 17, 2026 (record date February 27, 2026), with proposals to elect 10 director nominees, ratify Ernst & Young LLP as independent auditors for the year ending December 31, 2026, and approve NEO compensation on an advisory basis. The company reported $4.2B in 2025 sales from 71 manufacturing facilities across 20 countries serving 160+ countries, and outlined its RISE Strategy with 2030 targets including high single-digit to low double-digit sales CAGR, 19% average adjusted operating income margin, and mid-teens adjusted EPS CAGR. No declines or flat performance metrics were disclosed.

• ·Annual meeting voting deadline: April 16, 2026 (phone, internet, mail, or during virtual meeting)
• ·Fiscal year end: December 31
• ·2030 non-financial metrics: Safety, Growth, Productivity, Teamwork, Talent (equally weighted)

19-03-2026

On March 19, 2026, the Board of Directors of SR Bancorp, Inc. (SRBK) declared a cash quarterly dividend of $0.05 per share. The dividend is payable on April 15, 2026, to stockholders of record as of March 31, 2026. No other financial metrics or comparisons were disclosed in the filing.

• ·SR Bancorp, Inc. is an emerging growth company listed on NASDAQ under ticker SRBK.
• ·Filing signed by Christopher J. Pribula, CEO, on March 19, 2026.

19-03-2026

Brian O’Kelley resigned from the Board of Directors of LiveRamp Holdings, Inc. effective March 18, 2026, after serving since 2023. The resignation was not due to any disagreement with the Company on matters relating to its operations, policies, or practices. The filing was signed by Jerry C. Jones, EVP, Chief Ethics and Legal Officer and Secretary.

19-03-2026

Zions Bancorporation, N.A.'s 2026 proxy statement outlines the annual shareholder meeting on May 1, 2026, proposing the election of 11 directors (82% independent), ratification of Ernst & Young LLP as auditors for fiscal 2026, and an advisory vote approving 2025 named executive officer compensation, while recommending against a shareholder proposal on risks from policy-customer misalignment. Governance highlights include 100% independent standing committee membership, 45% board diversity, average director age of 66 and tenure of 12.5 years, and a CEO pay ratio of 64:1. No significant declines or flat metrics noted in governance disclosures.

• ·Record date: March 2, 2026
• ·Annual meeting location: Zions Bank Building Founders Room, 18th Floor, One South Main Street, Salt Lake City, Utah 84133
• ·Average director tenure: 12.5 years
• ·Average director age: 66
• ·CEO pay ratio: 64:1
• ·Shareholder right to call special meeting: by holders of 51% of votes entitled to be cast

19-03-2026

CVS Health Corporation elected John E. Gallina, former Executive Vice President and CFO of Elevance Health, Inc., to its Board of Directors effective March 19, 2026. Mr. Gallina, determined to be independent, was appointed to the Audit Committee and designated an 'audit committee financial expert' under SEC rules. His compensation will align with other non-employee directors, prorated from commencement.

• ·Mr. Gallina, age 66, served as CFO of Elevance from June 2016 through November 1, 2023, then as EVP and Advisor to the CEO until May 2024.
• ·Mr. Gallina holds a bachelor’s degree in business administration from The Ohio State University and is a certified public accountant.
• ·Director compensation practices described in CVS Health’s annual proxy statement filed April 4, 2025.

19-03-2026

AMERICAN BATTERY MATERIALS, INC. reported total assets of $396k as of Dec 31, 2025, up 23% YoY from $323k, driven by higher prepaid expenses, while cash plummeted 73% to $3k. The company posted a net loss of $6.4M for FY2025, worsening 49% YoY from $4.3M amid 19% higher operating expenses and increased other expenses; however, cash used in operations improved to $0.5M from $0.75M. Total liabilities surged 50% to $10.7M, deepening the stockholders' deficit to $10.3M from $6.8M.

• ·All 49,446 warrants expired during 2025.
• ·Weighted average common shares basic and diluted: 2,806,083 (FY2025) vs 2,377,691 (FY2024).
• ·Net loss per share: $(2.30) FY2025 vs $(1.81) FY2024.
• ·Convertible notes payable net: $5.6M (2025) up from $3.9M (2024).

19-03-2026

On March 18, 2026, Greg B. Maffei, Chair of the Board of Directors, and Albert E. Rosenthaler, a member of the Board, notified Tripadvisor, Inc. that they will not stand for re-election at the Company's 2026 Annual Meeting of Shareholders. Their decisions to retire were not due to any disagreement with the Company's operations, policies, or practices. The Company thanked them for their valuable service.

• ·Event reported on Form 8-K filed March 19, 2026
• ·Tripadvisor, Inc. incorporated in Nevada, NASDAQ: TRIP

19-03-2026

Evofem Biosciences, Inc. (Buyer) and Windtree Therapeutics, Inc. (Supplier) mutually terminated their License and Supply Agreement (dated March 20, 2025, as amended) effective March 13, 2026, because Windtree failed to establish manufacturing capabilities for Evofem's Phexxi product. No termination fees are due to either party, with each bearing their own costs, but Windtree must immediately cease using Evofem's IP and return all confidential information and assets. This termination eliminates the supply arrangement without further obligations, potentially disrupting Evofem's Phexxi production.

• ·Agreement governed by Delaware law with exclusive jurisdiction in Delaware courts.
• ·Certain sections of the original License and Supply Agreement (per Section 11.6) survive termination.

19-03-2026

Scorpius Holdings, Inc. entered into three non-convertible promissory notes with an institutional investor, with principal amounts of $30,426.95 (Feb 12, 2026), $190,907.77 (Feb 26, 2026), and $27,109.10 (Mar 11, 2026), totaling approximately $248,444. Each note carries 5% annual interest, a 15% premium on principal at maturity/redemption/prepayment, and matures in August-September 2026 or earlier upon corporate events or default. The notes impose short-term debt obligations with redemption rights using up to 100% of future financing proceeds and default triggers for unpaid indebtedness over $150,000.

• ·Notes issued in reliance on Section 4(a)(2) of the Securities Act and/or Regulation D exemption.
• ·Holder has right to require redemption of outstanding balance using up to 100% of gross proceeds from any subsequent Financing.

19-03-2026

FiscalNote reported Q4 2025 revenues of $22.2M, down 25% YoY from $29.5M primarily due to divestitures, with Adjusted EBITDA of $2.5M exceeding guidance but also down 25% YoY; full year 2025 revenue declined 21% to $95.4M while Adjusted EBITDA rose 5% to $10.3M. ARR fell 21% YoY to $84.1M (9% on pro forma basis excluding divestitures), reflecting execution challenges and sector instability, but new corporate logo bookings grew 39% YoY and multi-year private sector contracts increased from 17% to 40%. The company announced a ~25% workforce reduction, new AI-driven initiatives, and expects positive trailing 12-month FCF by end Q1 2027, amid an ongoing strategic review.

• ·Q4 2025 pro forma subscription revenue declined 8% YoY excluding divestitures.
• ·FY 2026 guidance: Total Revenues $80-83M, Adjusted EBITDA $14-16M (pro forma FY2025 comparison $90.7M rev, $9.0M Adj EBITDA).
• ·Q1 2026 guidance: Revenues $20-21M, Adjusted EBITDA ~$1M.
• ·Goodwill impairment of $12.4M in Q4 2025.
• ·Excluding non-cash and one-time items, Q4 operating expenses declined 12% YoY.

19-03-2026

Ollie's Bargain Outlet Holdings, Inc. (OLLI) reported FY2025 net sales of $2.65B, up 16.6% YoY from $2.27B in FY2024, with gross profit increasing 17.3% to $1.07B and net income rising 20.4% to $241M. The company expanded aggressively, opening 86 new stores (vs. 50 prior year) to reach 645 total stores, while comparable store sales grew 3.7% (up from 2.8%). However, product category sales mix remained largely flat YoY, with Consumables steady at 31.9%, Seasonal down slightly to 19.1%, and average net sales per store up modestly 1.3% to $4.3M.

• ·Adjusted EBITDA grew 17.0% YoY to $366M from $313M.
• ·Pre-opening expenses increased to $25.3M from $19.3M.
• ·Company does not expect to pay cash dividends for the foreseeable future.
• ·Board authorized to issue up to 50M shares of undesignated preferred stock without stockholder approval.

19-03-2026

Revelation Biosciences, Inc. held a Special Meeting of Stockholders on March 18, 2026, where shareholders overwhelmingly approved Proposal 1 to authorize the issuance of common stock pursuant to Class J Common Stock Warrants (issued January 26, 2026) to exceed Nasdaq's 20% Exchange Cap, with 4,033,345 votes for, 104,162 against, and 34,228 abstentions out of 4,171,735 shares present (quorum met from 10,492,469 outstanding shares). Proposal 2 for discretionary adjournment also passed strongly (4,044,322 for, 92,422 against). Following approval, the warrants' expiration date extends to March 18, 2031.

• ·Definitive proxy statement filed with SEC on February 17, 2026
• ·Warrant inducement letter dated January 23, 2026
• ·No broker non-votes on either proposal
• ·Common stock par value $0.001 per share

19-03-2026

Veeco Instruments Inc. filed a DEFA14A proxy statement for its 2026 Annual Meeting on May 7, 2026, proposing the election of three directors: Kathleen A. Bayless, Gordon Hunter, and Lena Nicolaides, Ph.D., to serve until the 2029 Annual Meeting. Additional proposals include approving an amendment to the 2019 Stock Incentive Plan to increase authorized common shares by 3,500,000, an advisory vote on named executive officer compensation, and ratification of KPMG LLP as the independent auditor for 2026. No financial metrics or performance data are disclosed in this procedural filing.

• ·Annual Meeting date and time: May 7, 2026, 8:30 AM EDT
• ·Vote deadline: May 6, 2026, 11:59 PM ET
• ·Materials request deadline: April 23, 2026
• ·In-person location: Terminal Drive, Plainview, New York 11803
• ·Virtual meeting: www.virtualshareholdermeeting.com/VECO2026

19-03-2026

Reviva Pharmaceuticals Holdings, Inc. (RVPH) announced a proposed public offering of shares of common stock (or equivalents) and warrants, with net proceeds intended to fund R&D activities including the RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia, alongside working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as the sole placement agent. However, the offering is subject to market and other conditions, with no assurance as to completion, timing, size, or terms.

• ·Shelf registration statement on Form S-3 (File No. 333-276848) filed February 2, 2024, effective February 13, 2024.
• ·References risks in Form 10-K for year ended December 31, 2024, and 10-Qs for quarters ended March 31, 2025, June 30, 2025, and September 30, 2025.

19-03-2026

Intellicheck, Inc. reported FY2025 revenues of $22.7M, up 13% YoY from $20.0M, with gross profit rising 13% to $20.5M and net income of $1.3M versus a $0.9M loss in 2024; Adjusted EBITDA surged to $2.6M from $0.5M. However, gross margin slipped slightly to 90.4% from 90.8%, R&D expenses increased 38% to $5.3M, and total operating expenses were essentially flat at $19.4M.

• ·Cash flows from operating activities: $4.5M in FY2025 vs $(2.7M) used in FY2024.
• ·Allowance for credit losses: $157k (2025) vs $100k (2024).
• ·Intangible assets, net: $2.1M (2025) down from $2.4M (2024).
• ·Weighted average basic shares: 19,546,473 (2025) vs 19,327,132 (2024).

19-03-2026

New Providence Acquisition Corp. III (NPACU), a SPAC, shared via social media on March 19, 2026, details of its proposed business combination with Abra Financial Holdings, Inc., pursuant to a Business Combination Agreement dated March 16, 2026, involving merger sub Aether Merger Sub I, Corp. The communication announces an upcoming Registration Statement on Form S-4, including a proxy statement/prospectus for SPAC shareholders, with standard advisories to review SEC filings for transaction details and risks. It emphasizes extensive forward-looking statement disclaimers and lists over 30 specific risks, including regulatory uncertainties in digital assets, potential failure to close, high transaction costs, and crypto market volatility.

• ·Commission File No.: 001-42610
• ·SPAC address: 401 S County Road #2588, Palm Beach, FL 33480
• ·IPO Prospectus filed with SEC on April 24, 2025

19-03-2026

York Space Systems reported full-year 2025 revenue of $386.2M, up 52% YoY from $253.5M, driven by Transport Layer Tranche 2 contracts, with gross profit surging 133% to $75.5M and gross margin expanding 6.8pp to 19.5%. However, net loss narrowed to $84.5M from $98.9M (-15%), while Adjusted EBITDA improved to -$8.3M from -$43.0M (-81%) but remained negative. Backlog grew to $543M after converting $319M to revenue, supported by acquisitions of ATLAS Space Operations and Orbion Space Technology, and 2026 revenue guidance of $545-595M.

• ·Liquidity of $312.6M as of Dec 31, 2025, increasing to $895.4M post-IPO as of Jan 31, 2026.
• ·IPO: 18.5M shares at $34 per share on Jan 30, 2026.
• ·Acquired ATLAS Space Operations in 2025; acquired Orbion Space Technology in March 2026.
• ·Dragoon mission delivered in 7 months from contract (75% timeline reduction vs. typical 30 months).
• ·2026 revenue outlook: $545M to $595M, with >70% from existing backlog at midpoint.

19-03-2026

Vince Holding Corp. (through V OPCO, LLC) entered into a Second Amendment to its Credit Agreement on March 18, 2026, with Bank of America, N.A. as agent, amending definitions related to Eligible Trade Receivables. Key changes include adjusting the general Concentration Limit to 20% and specific limits to 50% for Nordstrom (and affiliates), 35% for TJX and Macy’s (and affiliates), and 30% for Saks Global (and affiliates), along with modifications for account debtors in bankruptcy proceedings. The amendment confirms no Default or Event of Default exists and maintains all existing obligations.

• ·Original Credit Agreement dated June 23, 2023.
• ·First Amendment to Credit Agreement dated January 22, 2025.
• ·Amendment also updates clause (j) of Eligible Trade Receivables to allow Agent discretion for accounts from debtors in Chapter 11 operating as debtor-in-possession with super priority lien/administrative claim.

19-03-2026

InvenTrust Properties Corp. filed its definitive proxy statement (DEF 14A) on March 19, 2026, for the virtual Annual Meeting of Stockholders on May 5, 2026, at 9:00 a.m. Central Time. Stockholders of record as of March 2, 2026, will vote on electing eight directors, ratifying KPMG LLP as independent auditors for the year ending December 31, 2026, and an advisory 'say-on-pay' resolution for named executive officer compensation. The filing includes corporate governance details, director and executive compensation disclosures, audit committee report, and stockholder proposal information, with no financial performance metrics or period-over-period comparisons provided.

• ·Record date for stockholder voting: March 2, 2026
• ·Virtual meeting access: www.virtualshareholdermeeting.com/IVT2026
• ·Proxy materials furnished electronically per SEC rules

19-03-2026

DHT Holdings, Inc. filed its Form 20-F Annual Report on March 19, 2026. The excerpt provides definitions for key industry terms in the tanker shipping sector, including VLCC (very large crude carrier, 270,000-320,000 dwt), TCE (time charter equivalent), drydocking (every 30-60 months), and IMO 2020 (sulfur limit of 0.50% m/m effective January 1, 2020). It also includes a cautionary note on forward-looking statements regarding financial condition, acquisitions, business strategy, industry trends, and debt compliance.

• ·Drydocking required every 30 to 60 months.
• ·Special survey required at least once every five-year period.
• ·VLCCs can transport two million barrels or more of crude oil.